Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
On the eve of oral argument in the U.S. Supreme Court in the Wyeth v Levine pharmaceutical liability case, a new report was issued by the Center for Justice & Democracy challenging the drug industry's long-standing practice of aggressive marketing of high-risk products to women. Plaintiffs attorney Christopher Seeger, Seeger Weiss LLP, commented about the importance of the new study, The Bitterest Pill: How Drug Companies Fail to Protect Women and How Lawsuits Save Their Lives.
Sedgwick, Detert, Moran & Arnold LLP announces that New York Partner Linda A. Willett will assume leadership of the firm's Drug and Medical Device practice group. Willett, who joined Sedgwick earlier in 2008, is a former Bristol-Myers Squibb Company vice president and deputy general counsel. She brings tremendous insight and hands-on experience to the strategic and effective management of pharmaceutical manufacturer litigation
The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.
The parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.
This article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.
Active reading comprises many daily tasks lawyers engage in, including highlighting, annotating, note taking, comparing and searching texts. It demands more than flipping or turning pages.
There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.